Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim
Medtronic
Johnson and Johnson
Colorcon

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Investigational Drugs with Clinical Trials for: Squamous Cell Carcinoma of Head and Neck


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drugname Indication
BGB-A317 Squamous Cell Carcinoma of Head and Neck
BGB-3111 Squamous Cell Carcinoma of Head and Neck
IMC-1C11 Squamous Cell Carcinoma of Head and Neck
Raltitrexed Squamous Cell Carcinoma of Head and Neck
LEE011 Squamous Cell Carcinoma of Head and Neck
SGN-30 Squamous Cell Carcinoma of Head and Neck
>Drugname >Indication

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Express Scripts
McKinsey
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.